Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca diabetes drug recommended in Europe

April 23, 2012
Sales and Marketing AstraZeneca, CHMP, FDA, Merck, WHO, diabetes

AstraZeneca and Bristol-Myers Squibb’s new type II diabetes treatment Forxiga has received a positive opinion by European regulators.  The European …

News
AstraZeneca picture

AstraZeneca to buy Ardea for $1.3 billion

April 23, 2012
Research and Development, Sales and Marketing Ardea, AstraZeneca, febuxostat, gout

AstraZeneca is to buy Ardea Biosciences for $1 billion to help bolster its pipeline. Under the terms of the agreement, …

News

Petition launched to raise AF and stroke awareness

April 20, 2012
Business Services, Medical Communications, Sales and Marketing AF, Boehringer Ingelheim, Pradaxa, Xarelto, stroke

Various health organisations have called on more people involved in the management of atrial fibrillation (AF) to help raise awareness …

News
Gilenya

New safety warnings recommended for Gilenya

April 20, 2012
Medical Communications, Sales and Marketing EMA, Novartis, gilenya

A safety review of Novartis’ MS treatment Gilenya has concluded the drug should stay on the market, but that patients …

News
Facebook image

1 in 3 surveyed says social media changes attitudes to medicines

April 20, 2012
Business Services, Medical Communications, Sales and Marketing Facebook, Twitter, digital, pwC, social networking

A third of US social media users say it could change the way they think about their medicines, according to …

News
will

Hanson Zandi appoints two new directors

April 20, 2012
Business Services, Medical Communications, Sales and Marketing Hanson Zandi, health comms

Healthcare comms agency Hanson Zandi has made two new appointments with Damion Hampton and Will Elliott.  Hampton joins as account …

Appointment

Sylva Michelli joins Pegasus as associate director

April 20, 2012
Business Services, Medical Communications, Sales and Marketing Pegasus PR, Pegasus PR. Sylva Michelli, Sylva Michelli

Healthcare comms specialist Pegasus has appointed Sylva Michelli as associate director to strengthen the agency’s pharmaceutical and life sciences division.  …

Appointment

Kantar Health appoints Richard Goosey as UK senior director

April 20, 2012
Business Services, Medical Communications, Sales and Marketing Kantar Health, Richard Goosey, Roche

Consultancy and marketing insights company Kantar Health has appointed Richard Goosey as UK senior director of Advanced Methods. Goosey has …

Appointment

EMA request feedback on the draft EU reference dates

April 19, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

The European Medicines Agency has invited marketing-authorisation holders and other stakeholders to review and provide comments on the draft list …

News
Press release
GSK

GSK’s bid for Human Genome Sciences rejected

April 19, 2012
Sales and Marketing Benlysta, GSK, Human Genome Sciences, mergers and acquisitions

GlaxoSmithKline has launched a takeover bid for Human Genome Sciences for around $2.5 billion, but has been rejected by the …

News

Pharma R&D downsizing hits academic researchers

April 19, 2012
Research and Development ABPI, academic alliance, academic research

A survey of pharma’s research partnerships and funding of UK academics has raised concerns about the future of British science.The …

News
Severin Schwann

Roche abandons Illumina takeover bid

April 19, 2012
Sales and Marketing Diagnostics, Illumina, Roche, mergers and acquisitions

Roche has conceded defeat in its bid to buy Illumina, after shareholders of the diagnostics firm blocked the takeover – …

News

Kantar Health Names Goosey Senior Director, Advanced Methods in UK

April 18, 2012
Business Services Kantar Health, Richard Goosey, clinical statistics, market research

NEW YORK, April 18, 2012—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, has named Richard Goosey Senior …

News
Press release
avastin

NICE rejects Avastin for breast cancer

April 18, 2012
Sales and Marketing EMA, NICE, Roche, avastin, breast cancer

In a blow for Roche, NICE has turned down its cancer drug Avastin because of ‘too many uncertainties’ over cost …

News
cloud computing image

Pharmaceutical marketers – put your head in the clouds

April 17, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Blyth, Cloud Computing, MSI, digital, iPod, ipad

The moment has arrived for the pharma industry to embrace online planning tools.The convergence of reliable and secure cloud-based computing, …

Feature

China bans medicines formulated in toxic capsules

April 17, 2012
Manufacturing and Production China, SFDA, impurities, manufacturing

China’s State Food and Drug Administration (SFDA) has banned the sale of 13 medicines thought to be manufactured using contaminated …

News
Merck image

Merck does cancer drug deal with Endocyte

April 17, 2012
Research and Development, Sales and Marketing Cancer, Endocyte, Merck, NSCLC, vintafolide

Merck is to pay $120 million to US biopharma company Endocyte as part of a deal to develop and commercialise …

News

Pharma manufacturing news in brief

April 17, 2012
Manufacturing and Production Intertek and Pharmatek Labs, Jubilant, Penn Pharma

Raw material issues disrupting pharma production in Pakistan, Jubilant opens a new plant in Gujarat, plus updates from Penn Pharma, …

News
lechleiter_john_300dpi

Lilly’s John Lechleiter elected as PhRMA Board chairman

April 17, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, John Lechleiter, Pfizer, Sanofi, lilly

John Lechleiter, chairman, president and chief executive of Lilly has been elected chairman of the Pharmaceutical Research and Manufacturers of …

Appointment

Pharma baffled by NHS’ moving target

April 17, 2012
Sales and Marketing CCG, Cameron, Lansley, NHS, reforms

The reforms of England’s health service have now finally been passed into law, but the pharma industry will struggle to …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026